CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy.
Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Lee M. Nadler(Dana-Farber Cancer Institute), James D. Griffin(Harvard University), John G. Gribben(Queen Mary University of London), G J Freeman(Dana-Farber Cancer Institute), G S Gray(Dana-Farber Cancer Institute)
Cited by 116
Related Papers
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k